Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03257436 · ClinicalTrials.gov registry record · NA
Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
A NA study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 586
- Enrollment target
NCT03257436 is a NA study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 586 participants.
The verdict
NCT03257436, a NA study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 586 participants
- Enrollment target
Study Summary
Prospective, multi-center, single arm, post approval study to be conducted in the United States.
Interventions
- DEVICE CRT-D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 586 participants |
| Start Date | 2018-01-05 |
| Est. Completion | 2020-11-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03257436
The ClinicalTrials.gov registry entry for NCT03257436 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 586 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CRT-D is the first listed.
NCT03257436 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03257436 about?
NCT03257436 is a clinical study titled "Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)". Prospective, multi-center, single arm, post approval study to be conducted in the United States.
What is the current status of trial NCT03257436?
This trial is currently completed. It is a NA study. The enrollment target is 586 participants. The study started on 2018-01-05. Estimated completion is 2020-11-19.
What interventions are being tested in trial NCT03257436?
The interventions under investigation include: CRT-D (DEVICE).
Who is sponsoring clinical trial NCT03257436?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.